CLPT
Clearpoint Neuro Inc
10.90$
-4.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.2% | +12.2% | +2.9% | +3.4% | -4.3% | +9.2% | +8.6% | -3.8% | +17.5% | +16.5% | -10.3% | – | |
| – | +12.4% | +11.3% | -7.8% | +14.1% | -8.1% | +11.4% | +9.1% | -10.9% | +22.8% | +14.3% | -13.5% | – | |
| – | +22.6% | +12.8% | +10.2% | -2.8% | -1.8% | +7.8% | +8.3% | +0.8% | +14.4% | +17.9% | -8.4% | – | |
| – | +9.2% | -1.0% | +18.9% | +6.3% | +0.5% | +1.4% | +13.3% | -9.8% | -6.2% | +39.7% | +2.4% | – | |
| – | -6.2% | +4.4% | -2.4% | +13.8% | +2.3% | +26.4% | -17.0% | -6.0% | +83.4% | -14.5% | +11.1% | – | |
| – | +6.7% | +0.4% | +11.1% | +3.0% | +3.5% | +9.0% | -0.5% | -3.2% | +23.7% | +19.2% | +7.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | +578.8% | +29.5% | +96.6% | +2.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -97.9% | – | – | – | – | +38.9% | -68.0% | -50.0% | +100.0% | -575.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.